Keith Katkin
Director · Emergent BioSolutions Inc.
- 2026
- May 4, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Keith Katkin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael A. Metzger - $1.43M in SNDX purchases and sales in the last 12 months
- Nicholas A.J. Botwood - $1.18M in SNDX purchases and sales in the last 12 months
- Donald W. Degolyer - $444K in EBS purchases and sales in the last 12 months
- Sujata Tyagi Dayal - $201K in EBS purchases and sales in the last 12 months
- Kathryn C. Zoon - $144K in EBS purchases and sales in the last 12 months
- Keith A. Goldan - $137K in SNDX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Keith Katkin?
Keith Katkin is a corporate insider, tracked as Director of Emergent BioSolutions Inc. (EBS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Keith Katkin last file a Form 4?
The most recent primary Form 4 on record is dated 4 May 2026, one of 3 filings going back to 2026.
Has Keith Katkin been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($128K) across all tracked filings.
